ClinicalTrials.gg
Sign In
CompletedNCT00943033MBCTUpdated Sep 21, 2012

Study of Mindfulness-Based Cognitive Therapy

An interventional study of Mindfulness-Based Cognitive Therapy in Major Depressive Disorder, sponsored by Binghamton University. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-09-21.

Sponsored by Binghamton University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Research aimed at assessing changes in depressogenic thinking and the ability to disengage from depressogenic thinking following Mindfulness-Based Cognitive Therapy

02

Conditions studied

  • Major Depressive Disorder

Keywords

  • MBCT
  • Mindfulness-Based Cognitive Therapy
  • Mindfulness
  • Meditation
  • Relapse Prevention
  • Recurrent Depression
  • Depression
  • Major Depressive Disorder
03

In context

Depressive Disorder, Major

2,805 studies on the registry are indexed under Depressive Disorder, Major; 565 are open to participants now.

This study's enrollment of 48 is below the median of 80 across 2,338 interventional studies indexed under Depressive Disorder, Major.

Browse Depressive Disorder, Major studies →

Lead sponsor

Binghamton University is the lead sponsor of 12 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • History of two or more Major Depressive Episodes or history of a Major Depressive Episode lasting at least one year
  • Can speak, read, and understand English

Exclusion criteria

Exclusion Criteria:

  • Meet Criteria for Current Major Depressive Episode or are in partial remission
  • BDI-II score above 19
  • Abuse alcohol or drugs
  • Current Dysthymic Disorder
  • History of: psychosis when not depressed or intoxicated, Mania, Hypomania, Obsessive Compulsive Disorder, Posttraumatic Stress Disorder, Anorexia Nervosa, Bulimia Nervosa
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (actual)

Study arms

  • Experimental
    Mindfulness-Based Cognitive Therapy plus treatment as usual

    Behavioral: Mindfulness-Based Cognitive Therapy

  • No intervention
    MBCT Waitlist plus Treatment as Usual

Interventions

  • BehavioralMindfulness-Based Cognitive Therapy

    Mindfulness-Based Cognitive Therapy for the prevention of depressive relapse/recurrence

06

What researchers measure

Primary outcomes

  1. Sustained Attention to Response Task

    Time frame: zero to four weeks pre-treatment and zero to three weeks post-treatment

Secondary outcomes

  1. Five Facet Mindfulness Questionnaire

    Time frame: zero to four weeks pre-treatment and zero to three weeks post-treatment

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Aug 2009, a primary completion of Jul 2010 and a completion of Jul 2010. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 13, 2009
First posted
Jul 21, 2009
Start
Aug 2009
Primary completionActual
Jul 2010
CompletionActual
Jul 2010
Last update
Sep 21, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00943033
Lead sponsor
Binghamton University
Responsible party
Sean Barnes (PhD, Binghamton University) — Principal investigator
First posted
Jul 21, 2009
Start date
Aug 2009
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Sep 21, 2012

Study contacts

Sean M. Barnes, MS
principal investigator · Binghamton University SUNY

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Depressive Disorder, Major →

Other studies from this sponsor

Binghamton University

Start the discussion